Commercializing Personalized Medicine

To bring novel personalized medicines to patients, there needs to be a seamless blend of strategy and operations, particularly with the complexities of gene and cell therapies. This panel will discuss the key attributes of successful therapies to date, the skills and capabilities needed to succeed in this space, and how to enable patient access.